Drug intelligence / Profile preview

recombinant human frizzled-7 fc chimera

Development stage
Preclinical
Lead developer
R&D Systems
Modality
Fc-Fusion Proteins → Carrier/Scaffold Proteins → Recombinant Proteins and Enzymes
Administration
Intravenous
01

Overview

Recombinant human frizzled-7 fc chimera is a soluble fusion protein consisting of the extracellular domain of the human Frizzled-7 (FZD7) receptor fused to the Fc region of human IgG1. Frizzled-7 is a member of the G-protein coupled receptor superfamily and serves as a principal receptor for Wnt signaling proteins, which are critical regulators of cell fate, proliferation, and survival. By acting as a decoy receptor (or "Wnt trap"), this chimera binds to and sequesters secreted Wnt ligands, thereby preventing their interaction with endogenous cell-surface Frizzled receptors and inhibiting the activation of the canonical Wnt/beta-catenin signaling pathway. This mechanism is of significant interest in oncology, as aberrant Wnt signaling is a hallmark of various cancers, including hepatocellular carcinoma, colorectal cancer, and breast cancer. While primarily utilized as a high-potency research tool to study Wnt-dependent biological processes, similar Fc-fusion constructs have been explored as therapeutic agents to modulate developmental pathways in disease states.

Other names
Frizzled-7/Fc ChimeraFZD7-FcFZD-7-FcFZD 7-Fcsoluble Frizzled-7
02

Targets

WNT5A (Protein Wnt-5a)

Beyond the preview

Go deeper on recombinant human frizzled-7 fc chimera.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on recombinant human frizzled-7 fc chimera.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call